| Ytd | -12.73% | |
| 1y | -11.51% |
| Open | Prev Close | 25.44 | Low | High | Mkt Cap | 2.19B | |||
| Vol | 0.00 | Avg Vol | 1.48M | EPS | -2.01 | P/E | -12.66 | Forward P/E | -104.86 |
| Beta | N/A | Short Ratio | 3.36 | Inst. Own | 79.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 29.57 | 200-d Avg | 29.58 | 1yr Est | 37.00 |
The medical technology company reported a notable insider sale in recent filings.
Freedom Capital Markets analyst Gene Mannheimer initiates coverage on HeartFlow (NASDAQ:HTFL) wit